Browsing by Author "Moreno Martín-Retortillo, Lucas"
Now showing items 1-10 of 10
-
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors
Moreno Martín-Retortillo, Lucas; teira, pierre; Croop, James M.; Gerber, Nicolas U.; ANDRE, Nicolas; Gros Subias, Luís; AERTS, isabelle (Frontiers Media, 2023-05-24) -
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon
Pons Barcons, Guillem; Gallo, Gabriel Osvaldo; Navarro Barea, Natalia; Zarzosa Martinez, Patricia; Sansa Girona, Júlia; Garcia Gilabert, Lia; Magdaleno Cazon, Ainara; Segura Ginard, Miguel; Sánchez de Toledo Codina, Josep; Gallego Melcón, Soledad; Moreno Martín-Retortillo, Lucas; Roma Castanyer, Josep (MDPI, 2023-03-07) -
Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role
Giralt Buch, Irina; Gallo, Gabriel Osvaldo; Navarro Barea, Natalia; Zarzosa Martinez, Patricia; Pons Barcons, Guillem; Magdaleno Cazon, Ainara; Segura Ginard, Miguel; Sánchez de Toledo Codina, Josep; Moreno Martín-Retortillo, Lucas; Gallego Melcón, Soledad; Roma Castanyer, Josep (MDPI, 2021-08) -
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo
Giralt Buch, Irina; Gallo, Gabriel Osvaldo; Navarro Barea, Natalia; Zarzosa Martinez, Patricia; Pons Barcons, Guillem; Magdaleno Cazon, Ainara; Segura Ginard, Miguel; Sábado Álvarez, Constantino; Hladun Alvaro, Raquel; Sánchez de Toledo Codina, Josep; Moreno Martín-Retortillo, Lucas; Gallego Melcón, Soledad; Roma Castanyer, Josep (MDPI, 2021-11-29) -
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting
Park, Julie; Villablanca, Judith; Hero, Barbara; Kushner, Brian H.; Wheatley, Keith; Beiske, Klaus Hermann; Moreno Martín-Retortillo, Lucas (Wiley, 2022-11-01) -
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma
Navarro Barea, Natalia; Molist Muñoz, Carla; Sansa Girona, Júlia; Zarzosa Martinez, Patricia; Gallo, Gabriel Osvaldo; Pons Barcons, Guillem; Magdaleno Cazon, Ainara; Hladun Alvaro, Raquel; Garrido Pontnou, Marta; Segura Ginard, Miguel; Sánchez de Toledo Codina, Josep; Moreno Martín-Retortillo, Lucas; Gallego Melcón, Soledad; Roma Castanyer, Josep; Guillén Burrieza, Gabriela (Springer, 2022-10-11) -
Neuronal Differentiation-Related Epigenetic Regulator ZRF1 Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro
Jimenez Jimenez, Carlos Gonzalo; Antonelli, Roberta; Masanas Jimenez, Marc; Soriano Fernández, Aroa; Devis-Jauregui, Laura; Camacho Soriano, Jessica; Magdaleno Cazon, Ainara; Hladun Alvaro, Raquel; Jubierre Zapater, Luz; Roma Castanyer, Josep; Sánchez de Toledo Codina, Josep; Moreno Martín-Retortillo, Lucas; Gallego Melcón, Soledad; Segura Ginard, Miguel; Guillén Burrieza, Gabriela (MDPI, 2021-09-28) -
Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program
Jimenez Jimenez, Carlos Gonzalo; Antonelli, Roberta; Nadal-Ribelles, Mariona; Devis-Jauregui, Laura; Latorre Doménech, Pablo; Solé Serra, Carme; Masanas Jimenez, Marc; Molero Valenzuela, Adria; Soriano Fernández, Aroa; Sánchez de Toledo Codina, Josep; Llobet-Navas, David; Roma Castanyer, Josep; Posas, Francesc; de Nadal, Eulalia; Gallego Melcón, Soledad; Moreno Martín-Retortillo, Lucas; Segura Ginard, Miguel (BMC, 2022-09-03) -
Targeting the Hedgehog Pathway in Rhabdomyosarcoma
Zarzosa Martinez, Patricia; Garcia Gilabert, Lia; Hladun Alvaro, Raquel; Gallo, Gabriel Osvaldo; Pons Barcons, Guillem; Sansa Girona, Júlia; Segura Ginard, Miguel; Sánchez de Toledo Codina, Josep; Moreno Martín-Retortillo, Lucas; Gallego Melcón, Soledad; Roma Castanyer, Josep; Guillén Burrieza, Gabriela (MDPI, 2023-01-24) -
The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models
Masanas Jimenez, Marc; Masia Fandos, Nuria; Suarez Cabrera, Leticia; Olivan Riera, Mireia; Soriano Fernández, Aroa; Majem Cavaller, Blanca; Jimenez Jimenez, Carlos Gonzalo; Boloix Amenós, Ariadna; Toledano Martin, Ignasi; Navarro Jimenez, Alexandra; Sánchez de Toledo Codina, Josep; Roma Castanyer, Josep; Moreno Martín-Retortillo, Lucas; Gallego Melcón, Soledad; Santamaria Margalef, Anna; Segura Ginard, Miguel; Guillén Burrieza, Gabriela (Wiley, 2021-10)